WO2010079425A1 - System and method for placing a percutaneous valve device - Google Patents
System and method for placing a percutaneous valve device Download PDFInfo
- Publication number
- WO2010079425A1 WO2010079425A1 PCT/IB2010/000048 IB2010000048W WO2010079425A1 WO 2010079425 A1 WO2010079425 A1 WO 2010079425A1 IB 2010000048 W IB2010000048 W IB 2010000048W WO 2010079425 A1 WO2010079425 A1 WO 2010079425A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- valve
- valve device
- anchor
- support structure
- implantation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 75
- 238000002513 implantation Methods 0.000 claims abstract description 66
- 238000003032 molecular docking Methods 0.000 claims description 15
- 210000000709 aorta Anatomy 0.000 claims description 12
- 230000002861 ventricular Effects 0.000 claims description 9
- 210000001765 aortic valve Anatomy 0.000 description 9
- 210000003484 anatomy Anatomy 0.000 description 8
- 239000004743 Polypropylene Substances 0.000 description 5
- 210000003709 heart valve Anatomy 0.000 description 5
- -1 polypropylene Polymers 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000004087 circulation Effects 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 210000004115 mitral valve Anatomy 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 238000007792 addition Methods 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000001992 atrioventricular node Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004375 bundle of his Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000661 pacemaking effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2439—Expansion controlled by filaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
Definitions
- the present invention relates to prosthetic valve devices for implantation in the body and methods of placement thereof.
- the invention relates to a method of placing a valve device in a target location of a body lumen with enhanced accuracy.
- the invention further relates to placing a multi-component, or modular, prosthetic valve device with enhanced accuracy.
- the modular prosthetic valve device is a prosthetic valve capable of being delivered in parts and assembled in the body.
- the human body contains a wide variety of natural valves, such as, for example, heart valves, esophageal and stomach valves, intestinal valves, and valves within the lymphatic system. Natural valves can degenerate for a variety of reasons, such as disease, age, and the like.
- a malfunctioning valve fails to maintain the bodily fluid flow in a single direction with minimal pressure loss.
- An example of a malfunctioning valve is a heart valve that may be either stenotic, i.e., the leaflets of the valve are do not open fully , or regurgitant, i.e., the leaflets of the valve do not close properly. It is desirable to restore valve function to regain the proper functioning of the organ with which the valve is associated.
- proper valve function in the heart ensures that blood flow is maintained in a single direction through a valve with minimal pressure loss, so that blood circulation and pressure can be maintained.
- proper esophageal valve function ensures that acidic gastric secretions do not irritate or permanently damage the esophageal lining.
- Andersen, et. al. (U.S. Patent No. 5,411 ,552) comprises an expandable stent and a collapsible valve which is mounted onto the stent prior to deployment.
- the collapsible valve may be a biological valve or it may be made of synthetic material.
- the Anderson prosthetic valve is delivered and deployed using a balloon catheter which balloon is used to expand the valve-stent prosthesis to its final size. See also, U.S. Patent No. 6,168,614 (Andersen, et al.) entitled "Valve Prosthesis for Implantation in the Body” and U.S. Patent No. 5,840,081 (Andersen, et al.) entitled “System and Method for Implanting Cardiac Valves.”
- Spenser et. al. (U.S. Patent No. 6,893,460) describe another prosthetic valve device comprising a valve structure made of biological or synthetic material and a supporting structure, such as a stent.
- the Spenser prosthetic valve is a crimpable leafed-valve assembly consisting of a conduit having an inlet and an outlet, made of pliant material arranged to present collapsible walls at the outlet.
- the valve assembly is affixed to the support stent prior to deployment.
- the complete valve device is deployed at a target location within the body duct using a deploying means, such as a balloon catheter or a similar device.
- a prosthetic aortic valve that is placed too distally (relative to the heart, i.e., toward the aorta) can occlude or impede flow into the orifices of the coronary arteries.
- either the skirt of the prosthetic valve or large native valve leaflets, when pressed down against the aorta wall, may physically or functionally obstruct the orifices and impede coronary arterial flow.
- a prosthetic valve that is placed too proximally can interfere with the anterior leaflet of the Mitral valve, the atrioventricular node, or the bundle of His (conduction tissues).
- Approximately thirty percent of patients receiving prosthetic valves percutaneously require pacemakers, because the valve is placed with the ventricular end too close to or on top of the left bundle branch, putting pressure on the electrical conduction apparatus.
- the present invention relates to a system and method for positioning and placing an endovascular prosthetic valve device at a desired location of implantation, with improved accuracy.
- the method involves fixing one or more small anchors such as leading sutures or locating devices to the native anatomy of the lumen where the valve device is to be implanted, and using them to guide the placement of a prosthetic valve devices to the desired location.
- the anchor may directly engage a portion of the valve device, or the anchor may be threaded through a portion of the valve device to guide the threaded portion to the site of implantation, or the anchor may be attached to a placement wire, which placement wire may be threaded through a portion of the valve device to guide the threaded portion along the placement wire toward the anchor, i.e., to the site of implantation.
- the anchors may also be used to fix the valve device in place.
- the system and method of the invention are applicable not only to single unit percutaneous valve devices and those percutaneous valve devices assembled before delivery - as described in, for example, U.S. Patents 5,411 ,552 and 6,893,460 (representative of types of valve devices referred to herein as "pre-assembled" valve devices), but also to the lower profile, modular (multi-component) valve device, or valve assembly, described herein.
- the anchor is preferably operably connected to a portion of the valve device that is to be guided to the implantation site to seat the device, such as the frame of the valve device.
- the system and method of placing a prosthetic valve device percutaneously in a lumen confers improved accuracy of placement, simplified procedure, and increased efficacy. This permits such procedures to be performed in smaller and less sophisticated medical facilities with increased safety and superior results, thereby expanding the number of medical facilities equipped to perform percutaneous valve replacement procedures.
- FIGS. 1A-1 C illustrate three aspects of a system and method of placing a valve device at a desired location in a lumen using anchors and, in this embodiment, placement wires.
- FIG. 1A depicts the anchors fixed to the aorta wall.
- FIG. 1 B depicts the anchors fixed to the aortic surface of the native valve leaflets.
- FIG. 1C depicts the anchors fixed to the ventricular surface of the native valve leaflets.
- FIG. 2 illustrates a system and method of placing the valve device at a desired location in a lumen, wherein the anchors are leading sutures, positioned at the target site and used to guide the valve device to that position so as to position it with improved accuracy.
- the present invention provides a system for improved positioning of a valve device in a body lumen and a method for facilitating accurate positioning of a percutaneous valve device in a body lumen.
- Use of the system and methods of the invention is expected to improve outcomes and minimize complications and shorten hospital stays. Further, the method is expected to reduce patient trauma, simplify the procedure, and make the procedure available to more patients and more hospitals.
- the invention provides a system and method for accurate placement of implantable percutaneous prosthetic valve devices, systems and methods for percutaneously delivering and deploying implantable prosthetic heart valve devices and other implantable percutaneous prosthetic valve devices in body lumens.
- the placement system comprises the prosthetic valve device, an anchor, and a delivery device.
- the anchor is used to place the valve device at the desired location of valve implantation. Therefore, the anchor may first be placed at the desired site of valve implantation and then the valve device may be guided to that site. In this manner, the precise location of implantation may be chosen carefully and the anchor affixed or the location of the anchor adjusted. Then once the anchor is affixed, the prosthetic valve may be more efficiently placed and implanted, improving accuracy.
- the system may further include a placement wire which is attached to the anchor.
- the placement wire may have free ends for threading through a portion of valve device.
- the anchor is a leading suture
- the leading suture may be threaded through a portion of the valve device.
- the placement wire or leading suture may be threaded through part of the delivery system, such as the expansion balloon or system used for self-expanding support structures. The placement wire and leading suture are used to guide the prosthetic valve to the site of implantation.
- the threaded portion of the valve device may include loops or specific holes through which the placement wire or leading suture may be threaded, and may be the proximal edge (ventricle side) of the valve material.
- the threaded portion may inherently have open spaces for threading the placement wire or leading suture - for example, as on a support structure such as a stent.
- the anchor may be a docking apparatus and the portion of the valve device may have an anchor interface unit. In this embodiment, the anchor may directly engage a portion of the valve device.
- the valve device used with the placement system may be a preassembled percutaneous valve device, such as those described or known in the art.
- it may be modular percutaneous valve device, comprising a plurality of modules, as described in ffl]29-30, 32-34, 39-49 and Figs. 1a-4c of priority U.S. provisional patent application no. 61/144,007, in 1ffl37-47, 60-62, 65-82 and Figs. 1-6c of co-pending U.S. application no. (modular), entitled "Modular Percutaneous Valve Structure and
- the system and method of the invention are particularly adapted for use in percutaneous aortic valve replacement, but may also find use as replacements for other cardiac valves, such as, e.g., pulmonic, mitral and tricuspid valves, as well as valves in the peripheral vasculature or in other bodily lumens, such as the alimentary canal, lymph ducts, the biliary duct, and any other lumens having valves requiring replacement or needing valve implantation.
- the devices, systems and methods may also find application in animals.
- the placement system and method of the invention may be used with pre- assembled, percutaneous prosthetic valves, some of which are commercially available.
- preassembled, percutaneous prosthetic valves are described, for example, in U.S. Patent Nos. 5,411 ,552 and 6,893,460, and include, for example, the CoreValve RevalvingTM System from Medtronic/CoreValve Inc. (Irvine, CA, USA), Edwards-Sapien or Cribier-Edwards valves from Edwards Lifesciences (Irvine, CA, USA), and devices in development by AortTx (Palo Alto, CA, USA), Sadra Medical, Inc.
- the system and method of the invention are also applicable to a modular prosthetic valve device and system that allows a prosthetic valve device to be delivered safely into a lumen in a reduced diameter delivery device.
- One embodiment of the modular prosthetic valve device comprises two main device modules: a valve module and a support structure, which are designed to be assembled in the body, for example in the aorta or at the site of implantation.
- the support structure provides the framework, or backbone, of the device, housing the valve module and holding the valve module in place within the body.
- the valve module is the device module having the leaflets of the valve device and it provides a conduit having a inlet end and an outlet end.
- the valve module is a valve assembly that further comprises a plurality of valve sections, which may be assembled into the valve assembly in the body. The valve assembly may then be combined with the support structure into the assembled valve device.
- the valve module is a one-piece module that is delivered apart from the support structure and is combined with the support structure in the body. The one-piece valve module may be delivered as an unassembled, folded leaflets substructure or unassembled, folded leaflets-ring, and assembled so that it forms a conduit with leaflets prior to combining with the support structure.
- the modular valve device may be a valve assembly comprising a plurality of valve sections that may be deployed and assembled into a complete valve device without a support structure.
- valve module and support structure are delivered to a desired location in the lumen within an appropriate delivery device such as a catheter, for example an endovascular catheter.
- an appropriate delivery device such as a catheter, for example an endovascular catheter.
- FIGS. 1A-2 The use and operation of the valve placement embodiments of the invention are illustrated in FIGS. 1A-2. Note that the drawings are provided as an exemplary understanding of the present invention and to schematically illustrate particular embodiments of the present invention. The skilled artisan will readily recognize other similar examples equally within the scope of the invention. The drawings are not intended to limit the scope of the present invention as defined in the appended claims.
- Anchors 45 may be used to guide the delivery of the valve device, or a device module such as a support structure 20 of a modular valve device (as illustrated in FIGS. 1A-1C) to the target site.
- a placement system according to the invention comprises a prosthetic valve device and one or more anchors 45 and one or more placement wires 44.
- the placement wires 44 are connected to the anchors 45, as illustrated in FIGS. 1A-1C.
- the placement wires 44 may be threaded through and packaged with a device module, such as a support structure 20, of a modular valve device.
- anchors 45 may be used to guide any portion of the valve device to the target site, in particular with respect to pre-assembled percutaneous valve devices.
- placement wires 44 may be threaded through the valve portion of the device.
- the placement wires 44 may be threaded through the valve module or one or more valve sections, and the valve module may be combined with the support structure 20 prior to guiding the assembled valve device to the location of implantation 70.
- the placement wires 44 may be threaded through both the support structure 20 and valve module.
- the placement wires may be threaded through the delivery system.
- the anchors 45 are designed to be attached to native tissue in the lumen, specifically at the location of implantation 70.
- the placement wires 44 and anchors 45 may be used to guide the device module through which it is threaded, such as the support structure 20, and thus modular prosthetic valve device, to the desired location of implantation 70 within a body lumen, for example an aorta 81 , with improved accuracy.
- the placement wires may be threaded through a suitable part of the valve device, and used to guide the valve device to the desired location of implantation, similar to FIGS. 1A-1 C.
- the proximal portion of the "free ends" of the placement wires may exit the body at the proximal end of the delivery system, or may be attached to a portion of the delivery system.
- the prosthetic valve device may be guided into place along the placement wires 44 originating from the anchors 45.
- the support structure 20 may be guided into place along the placement wires 44.
- the anchors 45 may include a docking apparatus that may be connected directly to an anchor interface unit attached to the pre-assembled valve device, or support structure 20 of a modular valve device, that allows orientation of the valve device relative to the anchors 45.
- Anchor docking apparatus and anchor interface unit may be complementary so as to may lock together to secure the valve device at the target site.
- the support structure may be guided to the site of implantation prior to combining with the valve module, or the modular valve device may be assembled and then guided along the placement wires to be placed at the implantation site. Because it occurs after the delivery and assembly of the modular valve device, this latter embodiment of placing an assembled modular valve device is similar to placing a pre-assembled valve device, such as a percutaneous valve device in the art, in accordance with the invention. Assembly of the modular valve device proceeds as described above, either using a pull wire or a self-assembly member.
- the anchors 45 In addition to aiding in affixing the valve device to the target site, for example, by effecting "docking" of the device, the anchors 45 also may be used to facilitate attaching the device modules together thus aiding in assembly and triggering the locking mechanisms.
- Anchors 45 may include a button or rivet-type device, a hook, a percutaneously-inserted suture, interconnecting geometries, or any other type of docking apparatus device (not shown).
- the anchor includes an anchor docking apparatus
- a portion of the valve device comprises an anchor interface unit to engage the anchor docking apparatus.
- the anchor directly engages the valve device via the connection between the anchor docking apparatus and the anchor interface unit.
- the anchor docking apparatus and anchor interface unit combination may be any of male-female coupling type components, slotted hook mechanisms, hook and eye components, hook and groove components, interconnecting geometries (e.g., dovetail), press-fix connectors or similar components within the skill in the art.
- the anchors may be affixed to the native anatomy by puncturing the vessel wall and affixing two parts of the anchor to either side of the vessel.
- a catheter is used to direct a puncturing tool to the site of the vessel where the anchor is to be placed and the tool is used to create a hole in the vessel wall through which anchors may be affixed.
- the puncturing tool is removed from the catheter and the catheter is advanced through the newly formed opening in the vessel wall.
- the anchor is then deployed from the catheter on the outer side of the vessel wall.
- the catheter is then retracted through the hole and the remainder of the anchor is deployed on the inner side of the vessel wall.
- When fully deployed the anchor engages both sides of the vessel wall.
- the inner and outer portions of the anchor are held together by a "neck" portion of the anchor which occludes the opening in the vessel wall.
- Some embodiments of this invention may contain a reinforcing member in the anchor which can be used to provide an outward force against the circumference of the expanded diameter portion of the anchor so that the vessel wall is not compromised.
- tethers, or placement wires may be attached to the inner portion of the button anchor and used to guide the prosthetic valve device to the location of implantation and to secure the valve device at that location.
- the anchors may be hooks made of shape- memory alloy materials, such as Nitinol, and may be affixed to the native anatomy as follows.
- the anchors are delivered to the appropriate location in the lumen using a delivery device such as a catheter.
- the anchors may have a delivery configuration when housed in the catheter.
- the anchors revert to a pre-determined shape which is curved so as to grasp the vessel wall holding the anchor in place, like a hook.
- the deployed (pre-determined) shape of the anchor can be semi-circular, helical, or the like.
- This embodiment may have placement wires secured to the end of the hook anchor that does not penetrate the tissue, which placement wires may be used to guide and secure the prosthetic valve device to the desired location in the lumen.
- FIG. 2 illustrates an embodiment of a placement system of the invention in which the anchors are leading sutures 46.
- the leading suture 46 may be attached at one end to native tissue in the lumen at the desired location of valve implantation 70 via a hook, needle, or other similar device.
- the other end - the free end - of the leading suture 46 may be threaded through the valve device - in the embodiment depicted in FIG. 2, a modular valve device comprising a support structure 20 and valve module 55.
- the free ends of the leading sutures 46 are threaded through both the support structure 20 and valve module 55.
- the leading sutures 46 may be threaded through the valve device prior to deployment, e.g., packaged with the compressed/folded device modules in the catheter 60, or after delivery of the valve device to the body.
- the leading sutures 46 may be threaded through the delivery device or part of the devices used to expand the support structure, e.g., a balloon, or parts of devices used to release a self-expanding support structure.
- the valve device is a modular valve device
- the device modules, assembled or unassembled may be guided along the leading sutures 46 to the desired location of valve implantation 70 within a body lumen 80 with improved accuracy.
- the leading sutures 46 may be used to prevent migration of the valve device during balloon inflation.
- the proximal portion of the "free end" of the leading sutures may extend out the proximal end of the delivery device - i.e., outside the body, or may be attached to a portion of the delivery system.
- the invention further provides methods for placing a prosthetic valve device in a body lumen with improved accuracy.
- the method of placing a prosthetic valve device in a body lumen in need thereof comprises: affixing an anchor 45 in a body lumen 80 at a location of valve implantation 70; and positioning said prosthetic valve device at said location of valve implantation 70 using said anchor 80.
- the anchor 45 may be connected to a placement wire 44, and the placement wire 44 may be threaded through a portion of the valve device or delivery device prior to loading the valve device into the delivery device so that a free end of the placement wire 44 exits a proximal end of said delivery device (not shown).
- FIG. 1 A for reference, the method of placing a prosthetic valve device in a body lumen in need thereof, comprises: affixing an anchor 45 in a body lumen 80 at a location of valve implantation 70; and positioning said prosthetic valve device at said location of valve implantation 70 using said anchor 80.
- the anchor 45 may be connected to a placement wire 44,
- FIG. 1 A depicts the support structure 20 of a valve device having loops as a threaded portion 21 through which the placement wires 44 are threaded.
- the positioning step includes guiding the threaded portion 21 of the support structure 20 along the placement wire 44 to the location of valve implantation 70.
- placement wire 44 may be threaded through a portion of the valve device after the valve device is loaded into the delivery device or after deployment of the valve device from the delivery device.
- the affixing step may include affixing the anchor on the wall of the body lumen, or affixing the anchor on a proximal or distal side of a native valve leaflet.
- the body lumen may be an aorta with a myocardial valve having native valve leaflets.
- FIGS. 1A-1C illustrate where on the native anatomy of a myocardial valve the anchors may be positioned to optimize placement of the prosthetic valve device in an aorta 81.
- FIG. 1A illustrates the anchors 45 fixed to a lumen wall, e.g., the aorta wall 82 immediately distal to the native valve.
- FIG. 1B illustrates the anchors 45 affixed to a distal surface of the native valve leaflets 76, e.g., on the aortic surface 72.
- FIG. 1C illustrates the anchors 45 affixed to a proximal surface of the native valve leaflets 76, e.g., on the ventricular surface 74.
- the placement wires 44 may be threaded through the proximal edge of the valve device (or support structure), and the anchors 45 may be attached immediately proximal of the native valve.
- the placement wires 44 may be threaded through a more distal portion of the valve device, the anchors 5 may be attached to the body lumen more distally of the native valve leaflets 76 than illustrated in FIG.
- the anchors may be used to secure the valve device to the location of implantation or valve device may further comprise separate anchoring mechanisms (note shown) for securing said valve device to the location of implantation.
- the method may further comprise the step of securing the valve device to the lumen wall using the anchoring mechanisms.
- the leading sutures may similarly be threaded through a portion of said valve device or delivery device prior to loading said valve device into a delivery device or after deployment of the valve device.
- the leading sutures 46 shown in FIG. 1 In one embodiment of the method of placing a prosthetic valve device into a lumen in need of valve replacement or implantation using the leading sutures 46 shown in FIG.
- the method may comprise inserting percutaneously into the body lumen 80 a modular prosthetic valve system comprising a delivery device 60 containing device modules, for example a support structure 20 and a valve module 55, and a plurality of leading sutures 46, wherein each of the leading sutures 46 has a free end threaded through a portion of the device modules and exiting from a proximal end of the delivery device; advancing the delivery device to the location of valve implantation 70; attaching the leading sutures 46 to the location of valve implantation 70; retracting the delivery device from the location of valve implantation to a site of deployment; deploying the device modules; assembling the device modules into an assembled valve device; and guiding the assembled valve device along the leading sutures 46 to place the assembled valve device at said location of implantation 70.
- a modular prosthetic valve system comprising a delivery device 60 containing device modules, for example a support structure 20 and a valve module 55, and a plurality of leading sutures 46, wherein each of the leading sutures 46 has a free end thread
- the "free end" of the leading suture 46 may be attached to a portion of the delivery system.
- the leading sutures 46 may be threaded through a portion of support structure 20 and the support structure 20 may be guided to the location of implantation 70.
- the valve module then may be positioned and combined with the support structure 20 using pull wires or push rods (not shown).
- Either method may further comprise the step of affixing the assembled valve device to the location of valve implantation 70 using at least in part said leading sutures 46.
- the leading sutures 46 may be attached to the body lumen just distal of the native valve leaflets 76 (see also FIG. 1A).
- leading sutures 46 may be attached to the aortic surface or ventricular surface of the native valve leaflets 76, as depicted for the anchors 45 in FIGS. 1B and 1C, respectively.
- the leading sutures 46 may be threaded through the proximal edge of the valve device and may be attached immediately proximal of the native valve leaflets 76. for example, to the ventricular surface in an aortic valve replacement (not shown).
- the leading sutures 46 may be threaded through a more distal portion of the valve device, and the leading sutures 46 may be attached to the body lumen more distally of the native valve leaflets 76 than illustrated in FIG. 2. Placement of a pre-assembled valve device in accordance with the invention may proceed in a similar manner, but without the need for assembling device modules.
- the leading sutures may first be affixed to the body lumen and then the valve device may be introduced.
- the method of placing a prosthetic valve device into a lumen 80 in need of valve replacement or implantation may comprise attaching leading sutures 46 in a lumen 80 at a desired location of valve implantation 70; inserting percutaneously into a body lumen 80 a delivery device 60 containing a valve device; advancing the delivery device to a deployment site; deploying the valve device into the body lumen 80; threading the leading sutures 46 through a portion of the valve device; and guiding the valve device along the leading sutures 46 to position the valve device at the location of valve implantation 70.
- the leading sutures may be threaded through the assembled valve device after assembly of the device modules, or the leading sutures may be threaded through the device modules after deployment and prior to assembly (not shown).
- the system and method of the invention also encompass placing a pre- assembled percutaneous valve device.
- the placement wires or leading sutures may be threaded through, for example, the frame of the percutaneous valve, i.e., the portion of the device that is expanded to seat the valve at the location of implantation.
- the placement wires or leading sutures may be threaded through the skirt or proximal (ventricular) end of the valve material.
- the placement wires or leading sutures may be threaded through a portion of the delivery system or the components or portions of components used to expand the compressed valve device, such as for example a balloon component, or in the case of valve devices having self-expanding members, the components involved in release of the self-expanding member.
- the pre-assembled valve device then may be guided over the placement wires or leading sutures to the implantation spot.
- one or two leading sutures or placement wires, or a ring of three or more sutures may be used.
- the methods of the invention improve the accuracy of placing the percutaneous valve device, and may improve the speed with which precise placement of the valve device is made.
- an anchor or "a leading suture”
- the embodiment may include one or more anchors or one or more leading sutures.
- a placement wire is described, one or more may be used, but generally one placement wire is used with one appropriate type of anchor.
- the anchor(s) is positioned first, and its position may be changed if necessary, prior to deployment of the valve device or device modules from the delivery device, prior to assembly of a modular valve device, or even prior to percutaneous insertion of the valve device, but always prior to placement of the valve device.
- Materials useful for leading sutures in accordance with the invention include, for example, silk, metal, polyester, polypropylene, or other standard suture material known in the art.
- Types of polyester sutures may include, for example, 2-0 polyester (braided or unbraided).
- Types of polypropylene suture may include, for example, double-armed 4-0 polypropylene, 5-0 polypropylene, or 6-0 polypropylene.
- Percutaneous placement of sutures may be performed by adapting methods known in the art for percutaneous closure suturing.
- the leading suture may be placed at the site of implantation using a system comprising two catheters (a guide catheter and therapy catheter) similar to that described by Webb, J. G. et al., "Percutaneous suture edge-to-edge repair of the mitral valve," EUROINTERVENTION 5:86-89 (2009).
- the guide catheter may be advanced to the target site of implantation.
- the "therapy catheter” (which contains one or more needles with the attached leading suture and needle catchers, an actuator trigger and an open window through which the needle and needle catcher can exit) may then be advanced through the guide catheter to the target, the window oriented toward the anchor placement site, and the actuator trigger made to drive the needle through the native tissue at the site of implantation and into the needle catcher.
- the therapy needle then may be sequentially rotated along its axis to one or more additional anchor sites radially displaced from the previous site, and the actuator trigger made to activate additional needles. As the therapy catheter is removed, one or more leading suture loops have been anchored at the site of valve implantation.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10702733.6A EP2379012B1 (en) | 2009-01-12 | 2010-01-13 | System for placing a percutaneous valve device |
CA2749578A CA2749578C (en) | 2009-01-12 | 2010-01-13 | System and method for placing a percutaneous valve device |
GB1111849A GB2478263A (en) | 2009-01-12 | 2010-01-13 | System and method for placing a percutaneous valve device |
SE1050838A SE537857C2 (en) | 2009-01-12 | 2010-01-13 | System for placing a percutaneous prosthetic valve device |
AU2010204156A AU2010204156B2 (en) | 2009-01-12 | 2010-01-13 | System and method for placing a percutaneous valve device |
JP2011544942A JP5627602B2 (en) | 2010-01-12 | 2010-01-13 | System and method for deploying a percutaneous valve device |
ES10702733.6T ES2587628T3 (en) | 2009-01-12 | 2010-01-13 | System for placing a percutaneous valve device |
EA201190038A EA027432B1 (en) | 2009-01-12 | 2010-01-13 | System and method for placing a percutaneous valve device |
HK11112398.0A HK1158051A1 (en) | 2009-01-12 | 2011-11-16 | System for placing a percutaneous valve device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14400709P | 2009-01-12 | 2009-01-12 | |
US61/144,007 | 2009-01-12 | ||
US12/686,337 US9681950B2 (en) | 2009-01-12 | 2010-01-12 | System and method for placing a percutaneous valve device |
US12/686,337 | 2010-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010079425A1 true WO2010079425A1 (en) | 2010-07-15 |
Family
ID=42316292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2010/000048 WO2010079425A1 (en) | 2009-01-12 | 2010-01-13 | System and method for placing a percutaneous valve device |
Country Status (10)
Country | Link |
---|---|
US (2) | US9681950B2 (en) |
EP (1) | EP2379012B1 (en) |
AU (1) | AU2010204156B2 (en) |
CA (1) | CA2749578C (en) |
EA (1) | EA027432B1 (en) |
ES (1) | ES2587628T3 (en) |
GB (1) | GB2478263A (en) |
HK (1) | HK1158051A1 (en) |
SE (1) | SE537857C2 (en) |
WO (1) | WO2010079425A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104540474A (en) * | 2012-06-19 | 2015-04-22 | 波士顿科学国际有限公司 | Replacement heart valve |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
US9402720B2 (en) | 2009-01-12 | 2016-08-02 | Valve Medical Ltd. | Modular percutaneous valve structure and delivery method |
WO2011041571A2 (en) | 2009-10-01 | 2011-04-07 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US8795354B2 (en) * | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9579193B2 (en) | 2010-09-23 | 2017-02-28 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
US10321998B2 (en) | 2010-09-23 | 2019-06-18 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9364326B2 (en) | 2011-06-29 | 2016-06-14 | Mitralix Ltd. | Heart valve repair devices and methods |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021375A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9549817B2 (en) | 2011-09-22 | 2017-01-24 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US12053378B2 (en) | 2012-11-07 | 2024-08-06 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
EP4166111A1 (en) | 2013-01-24 | 2023-04-19 | Cardiovalve Ltd. | Ventricularly-anchored prosthetic valves |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US20170014115A1 (en) | 2014-03-27 | 2017-01-19 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
US9700412B2 (en) | 2014-06-26 | 2017-07-11 | Mitralix Ltd. | Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices |
EP4066786A1 (en) | 2014-07-30 | 2022-10-05 | Cardiovalve Ltd. | Articulatable prosthetic valve |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US20160235525A1 (en) | 2015-02-12 | 2016-08-18 | Medtronic, Inc. | Integrated valve assembly and method of delivering and deploying an integrated valve assembly |
JP6624791B2 (en) * | 2015-02-25 | 2019-12-25 | テルモ株式会社 | Medical instruments, medical instrument assemblies, balloon devices |
WO2017049003A1 (en) | 2015-09-15 | 2017-03-23 | Nasser Rafiee | Devices and methods for effectuating percutaneous glenn and fontan procedures |
CN108601645B (en) | 2015-12-15 | 2021-02-26 | 内奥瓦斯克迪亚拉公司 | Transseptal delivery system |
EP4183372A1 (en) | 2016-01-29 | 2023-05-24 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
WO2017187312A1 (en) | 2016-04-25 | 2017-11-02 | Valfix Medical Ltd. | Percutaneous valve repair and replacement |
US10588745B2 (en) | 2016-06-20 | 2020-03-17 | Medtronic Vascular, Inc. | Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis |
US20190231525A1 (en) | 2016-08-01 | 2019-08-01 | Mitraltech Ltd. | Minimally-invasive delivery systems |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
CA3031187A1 (en) | 2016-08-10 | 2018-02-15 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
EP3541462A4 (en) | 2016-11-21 | 2020-06-17 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
EP3576677B1 (en) | 2017-02-02 | 2021-06-23 | Valfix Medical Ltd. | Percutaneous valve repair and replacement |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US11058411B2 (en) | 2019-01-14 | 2021-07-13 | Valfix Medical Ltd. | Anchors and locks for percutaneous valve implants |
CA3132873A1 (en) | 2019-03-08 | 2020-09-17 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
CN113811265A (en) | 2019-04-01 | 2021-12-17 | 内奥瓦斯克迪亚拉公司 | Prosthetic valve deployable in a controlled manner |
AU2020271896B2 (en) | 2019-04-10 | 2022-10-13 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
WO2020236931A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
WO2020257643A1 (en) | 2019-06-20 | 2020-12-24 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5840081A (en) | 1990-05-18 | 1998-11-24 | Andersen; Henning Rud | System and method for implanting cardiac valves |
US5868762A (en) | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
US5928250A (en) | 1997-01-30 | 1999-07-27 | Nissho Corporation | Catheter assembly for intracardiac suture |
US6042601A (en) | 1998-03-18 | 2000-03-28 | United States Surgical Corporation | Apparatus for vascular hole closure |
US6056760A (en) | 1997-01-30 | 2000-05-02 | Nissho Corporation | Device for intracardiac suture |
US20040138741A1 (en) * | 2000-07-27 | 2004-07-15 | Robert Stobie | Heart valve holders and handling clips therefor |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US20050283231A1 (en) * | 2004-06-16 | 2005-12-22 | Haug Ulrich R | Everting heart valve |
US20060195184A1 (en) * | 2005-02-28 | 2006-08-31 | Ernest Lane | Conformable prosthesis for implanting two-piece heart valves and methods for using them |
WO2007009117A1 (en) * | 2005-07-13 | 2007-01-18 | Arbor Surgical Technologies, Inc. | Two-piece percutaneous prosthetic heart valves and methods for making and using them |
WO2007097983A2 (en) * | 2006-02-14 | 2007-08-30 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5891160A (en) * | 1996-02-23 | 1999-04-06 | Cardiovascular Technologies, Llc | Fastener delivery and deployment mechanism and method for placing the fastener in minimally invasive surgery |
US5800531A (en) * | 1996-09-30 | 1998-09-01 | Baxter International Inc. | Bioprosthetic heart valve implantation device |
US6312464B1 (en) * | 1999-04-28 | 2001-11-06 | NAVIA JOSé L. | Method of implanting a stentless cardiac valve prosthesis |
RU2200507C2 (en) | 2000-12-06 | 2003-03-20 | Закрытое Акционерное Общество Научно-Производственное Предприятие "Мединж" | Cardiac valve prosthesis |
US6733525B2 (en) * | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
AU2003247526A1 (en) * | 2002-06-12 | 2003-12-31 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US20050075728A1 (en) * | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
US7597711B2 (en) * | 2004-01-26 | 2009-10-06 | Arbor Surgical Technologies, Inc. | Heart valve assembly with slidable coupling connections |
US20060135967A1 (en) * | 2004-11-22 | 2006-06-22 | Fidel Realyvasquez | Method and apparatus for attaching a valve prosthesis |
US8083793B2 (en) * | 2005-02-28 | 2011-12-27 | Medtronic, Inc. | Two piece heart valves including multiple lobe valves and methods for implanting them |
CN101180010B (en) * | 2005-05-24 | 2010-12-01 | 爱德华兹生命科学公司 | Rapid deployment prosthetic heart valve |
US20070001628A1 (en) * | 2005-06-30 | 2007-01-04 | Iq Group Sdn Bhd | Integral detector-lighting apparatus with multiple mounting orientations |
WO2007130880A1 (en) | 2006-04-29 | 2007-11-15 | Arbor Surgical Technologies, Inc | Guide shields for multiple component prosthetic heart valve assemblies and apparatus and methods for using them |
US20070293942A1 (en) * | 2006-06-16 | 2007-12-20 | Daryush Mirzaee | Prosthetic valve and deployment method |
US8241351B2 (en) * | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
-
2010
- 2010-01-12 US US12/686,337 patent/US9681950B2/en not_active Expired - Fee Related
- 2010-01-13 EA EA201190038A patent/EA027432B1/en not_active IP Right Cessation
- 2010-01-13 AU AU2010204156A patent/AU2010204156B2/en not_active Ceased
- 2010-01-13 GB GB1111849A patent/GB2478263A/en not_active Withdrawn
- 2010-01-13 WO PCT/IB2010/000048 patent/WO2010079425A1/en active Application Filing
- 2010-01-13 CA CA2749578A patent/CA2749578C/en not_active Expired - Fee Related
- 2010-01-13 SE SE1050838A patent/SE537857C2/en not_active IP Right Cessation
- 2010-01-13 ES ES10702733.6T patent/ES2587628T3/en active Active
- 2010-01-13 EP EP10702733.6A patent/EP2379012B1/en not_active Not-in-force
-
2011
- 2011-11-16 HK HK11112398.0A patent/HK1158051A1/en not_active IP Right Cessation
-
2017
- 2017-05-12 US US15/593,367 patent/US20170296334A1/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5840081A (en) | 1990-05-18 | 1998-11-24 | Andersen; Henning Rud | System and method for implanting cardiac valves |
US6168614B1 (en) | 1990-05-18 | 2001-01-02 | Heartport, Inc. | Valve prosthesis for implantation in the body |
US5928250A (en) | 1997-01-30 | 1999-07-27 | Nissho Corporation | Catheter assembly for intracardiac suture |
US6056760A (en) | 1997-01-30 | 2000-05-02 | Nissho Corporation | Device for intracardiac suture |
US5868762A (en) | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
US6042601A (en) | 1998-03-18 | 2000-03-28 | United States Surgical Corporation | Apparatus for vascular hole closure |
US20040138741A1 (en) * | 2000-07-27 | 2004-07-15 | Robert Stobie | Heart valve holders and handling clips therefor |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US20050283231A1 (en) * | 2004-06-16 | 2005-12-22 | Haug Ulrich R | Everting heart valve |
US20060195184A1 (en) * | 2005-02-28 | 2006-08-31 | Ernest Lane | Conformable prosthesis for implanting two-piece heart valves and methods for using them |
WO2007009117A1 (en) * | 2005-07-13 | 2007-01-18 | Arbor Surgical Technologies, Inc. | Two-piece percutaneous prosthetic heart valves and methods for making and using them |
WO2007097983A2 (en) * | 2006-02-14 | 2007-08-30 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
Non-Patent Citations (4)
Title |
---|
PIAZZA, N. ET AL.: "Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve", CIRCULATION CARDIOVASCULAR INTERVENTIONS, vol. 1, 2008, pages 74 - 81, XP055172634, DOI: doi:10.1161/CIRCINTERVENTIONS.108.780858 |
PIAZZA, N. ET AL.: "Early and persistent intraventricular conduction abnormalities and requirements for pacemaking following percutaneous replacement of the aortic valve", JACC CARDIOVASCULAR INTERVENTIONS, vol. 1, 2008, pages 310 - 316, XP022734883, DOI: doi:10.1016/j.jcin.2008.04.007 |
WEBB, J.G. ET AL.: "Percutaneous suture edge-to-edge repair of the mitral valve", EUROINTERVENTION, vol. 5, 2009, pages 86 - 89 |
WEBB, JG ET AL.: "Percutaneous aortic valve implantation retrograde from the femoral artery", CIRCULATION, vol. 113, 2006, pages 842 - 850 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104540474A (en) * | 2012-06-19 | 2015-04-22 | 波士顿科学国际有限公司 | Replacement heart valve |
Also Published As
Publication number | Publication date |
---|---|
GB2478263A (en) | 2011-08-31 |
CA2749578C (en) | 2018-08-21 |
EA201190038A1 (en) | 2012-06-29 |
AU2010204156B2 (en) | 2015-01-22 |
AU2010204156A1 (en) | 2011-07-07 |
EP2379012B1 (en) | 2016-08-03 |
CA2749578A1 (en) | 2010-07-15 |
EP2379012A1 (en) | 2011-10-26 |
EA027432B1 (en) | 2017-07-31 |
HK1158051A1 (en) | 2012-07-13 |
SE537857C2 (en) | 2015-11-03 |
US20170296334A1 (en) | 2017-10-19 |
SE1050838A1 (en) | 2011-01-17 |
US20100179648A1 (en) | 2010-07-15 |
US9681950B2 (en) | 2017-06-20 |
ES2587628T3 (en) | 2016-10-25 |
GB201111849D0 (en) | 2011-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010204156B2 (en) | System and method for placing a percutaneous valve device | |
AU2020286209B2 (en) | Mitral valve prosthesis | |
US20230149158A1 (en) | Modular percutaneous valve structure and delivery method | |
EP4099957B1 (en) | Transcatheter heart valve prosthesis assembled inside heart chambers | |
US10226337B2 (en) | Method and apparatus for fine adjustment of a percutaneous valve structure | |
EP2445450B1 (en) | Unitary quick-connect prosthetic heart valve | |
AU2009206672A1 (en) | Delivery systems and methods of implantation for prosthetic heart valves | |
JP5627602B2 (en) | System and method for deploying a percutaneous valve device | |
IE85827B1 (en) | System and method for placing a percutaneous valve device | |
AU2017204775B2 (en) | Method and apparatus for fine adjustment of a percutaneous valve structure | |
IE85818B1 (en) | Method and apparatus for fine adjustment of a percutaneous valve structure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10702733 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10201000001777 Country of ref document: CH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010204156 Country of ref document: AU Ref document number: 201190038 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 2011544942 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2010204156 Country of ref document: AU Date of ref document: 20100113 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1111849 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20100113 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1111849.4 Country of ref document: GB |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2749578 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2010702733 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010702733 Country of ref document: EP |